CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization


– Conference call to be held at 8:45 am EDT – SOUTH PLAINFIELD, N.J., Sept. 15, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on…

Leave a Reply